BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10503942)

  • 1. Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats.
    Matsui H; Morishima I; Numaguchi Y; Toki Y; Okumura K; Hayakawa T
    Life Sci; 1999; 65(12):1265-74. PubMed ID: 10503942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
    Oliveira PJ; Bjork JA; Santos MS; Leino RL; Froberg MK; Moreno AJ; Wallace KB
    Toxicol Appl Pharmacol; 2004 Oct; 200(2):159-68. PubMed ID: 15476868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy.
    Santos DL; Moreno AJ; Leino RL; Froberg MK; Wallace KB
    Toxicol Appl Pharmacol; 2002 Dec; 185(3):218-27. PubMed ID: 12498738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Administration of Carvedilol Protected against Doxorubicin-Induced Cardiomyopathy.
    Chen YL; Chung SY; Chai HT; Chen CH; Liu CF; Chen YL; Huang TH; Zhen YY; Sung PH; Sun CK; Chua S; Lu HI; Lee FY; Sheu JJ; Yip HK
    J Pharmacol Exp Ther; 2015 Dec; 355(3):516-27. PubMed ID: 26511374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yogurt Containing the Probacteria Lactobacillus acidophilus Combined with Natural Antioxidants Mitigates Doxorubicin-Induced Cardiomyopathy in Rats.
    Abu-Elsaad NM; Abd Elhameed AG; El-Karef A; Ibrahim TM
    J Med Food; 2015 Sep; 18(9):950-9. PubMed ID: 25590792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of carvedilol alone and coadministered with diltiazem and prednisolone on doxorubicin and 5-fluorouracil-induced hepatotoxicity and nephrotoxicity in rats.
    Akindele AJ; Oludadepo GO; Amagon KI; Singh D; Osiagwu DD
    Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary fish oil does not prevent doxorubicin-induced cardiomyopathy in rats.
    Matsui H; Morishima I; Hayashi K; Kamiya H; Saburi Y; Okumura K
    Can J Cardiol; 2002 Mar; 18(3):279-86. PubMed ID: 11907617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
    Zhang QL; Yang JJ; Zhang HS
    Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-oxidants and apoptosis: attenuation of doxorubicin induced cardiomyopathy by carvedilol.
    Armstrong SC
    J Mol Cell Cardiol; 2004 Oct; 37(4):817-21. PubMed ID: 15380672
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
    Mohamed HE; Asker ME; Ali SI; el-Fattah TM
    J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of carnosine and carnosine plus vitamin E treatments on doxorubicin-induced oxidative stress and cardiac, hepatic, and renal toxicity in rats.
    Kumral A; Giriş M; Soluk-Tekkeşin M; Olgaç V; Doğru-Abbasoğlu S; Türkoğlu Ü; Uysal M
    Hum Exp Toxicol; 2016 Jun; 35(6):635-43. PubMed ID: 26224044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
    Yuan Z; Shioji K; Kihara Y; Takenaka H; Onozawa Y; Kishimoto C
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H83-90. PubMed ID: 14684360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc accumulation in adriamycin-induced cardiomyopathy in rats: effects of melatonin, a cardioprotective antioxidant.
    Morishima I; Okumura K; Matsui H; Kaneko S; Numaguchi Y; Kawakami K; Mokuno S; Hayakawa M; Toki Y; Ito T; Hayakawa T
    J Pineal Res; 1999 May; 26(4):204-10. PubMed ID: 10340722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats.
    Morishima I; Matsui H; Mukawa H; Hayashi K; Toki Y; Okumura K; Ito T; Hayakawa T
    Life Sci; 1998; 63(7):511-21. PubMed ID: 9718077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
    Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
    J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of S-carvedilol on doxorubicin-induced damages to human umbilical vein endothelial cells and rats.
    Wu T; Li H; Lan Q; Zhao ZA; Cao Y; Zhou P; Wan S; Zhang J; Jiang H; Zhang Q; Pang J
    J Appl Toxicol; 2019 Aug; 39(8):1233-1244. PubMed ID: 31066085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of metoprolol with low, middle and high doses of carvedilol in prevention of postinfarction left ventricular remodeling in rats.
    Yang Y; Tang Y; Ruan Y; Wang Y; Gao R; Chen J; Chen Z
    Jpn Heart J; 2003 Nov; 44(6):979-88. PubMed ID: 14711192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
    Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G
    J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exercise protects against doxorubicin cardiotoxicity.
    Wonders KY; Hydock DS; Schneider CM; Hayward R
    Integr Cancer Ther; 2008 Sep; 7(3):147-54. PubMed ID: 18815146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.